Milestone Pharmaceuticals (MIST)
(Delayed Data from NSDQ)
$1.51 USD
-0.04 (-2.63%)
Updated Sep 23, 2024 02:39 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.14 |
Last EPS Surprise | 26.32% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.71 |
Next Year | -1.12 |
EPS (TTM) | -1.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 5.43M |
# of Estimates | NA | NA | NA | 3 |
High Estimate | NA | NA | NA | 10.80M |
Low Estimate | NA | NA | NA | 1.49M |
Year ago Sales | 0.00M | 0.00M | 1.00M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.21 | -0.71 | -1.12 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.13 | -0.14 | -0.60 | -0.70 |
High Estimate | -0.13 | -0.14 | -0.54 | -0.52 |
Low Estimate | -0.24 | -0.26 | -0.94 | -1.88 |
Year ago EPS | -0.35 | -0.32 | -1.39 | -0.71 |
Year over Year Growth Est. | 48.57% | 34.38% | 48.92% | -58.10% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.21 | -0.71 | -1.12 |
7 Days Ago | -0.18 | -0.21 | -0.71 | -1.12 |
30 Days Ago | -0.18 | -0.21 | -0.70 | -1.12 |
60 Days Ago | -0.18 | -0.20 | -0.79 | -1.22 |
90 Days Ago | -0.18 | -0.20 | -0.79 | -1.22 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.21 | -0.60 | -1.12 |
Zacks Consensus Estimate | -0.18 | -0.21 | -0.71 | -1.12 |
Earnings ESP | 0.00% | 0.00% | 14.89% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.14 | -0.21 | -0.32 | -0.35 | NA |
Estimate | -0.19 | -0.26 | -0.30 | -0.38 | NA |
Difference | 0.05 | 0.05 | -0.02 | 0.03 | 0.03 |
Surprise | 26.32% | 19.23% | -6.67% | 7.89% | 11.69% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more